Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Sacklers Deny Personal Responsibility for Opioid Epidemic in House Hearing [View all]
Source: New York Times
Sacklers Deny Personal Responsibility for Opioid Epidemic in House Hearing
It was the first time in years that members of the family that owns Purdue Pharma have taken questions publicly, and the exchanges were tense.
By Jan Hoffman
Dec. 17, 2020, 2:28 p.m. ET
Members of Congress on Thursday hurled withering comments and furious questions at two members of the billionaire Sackler family that owns Purdue Pharma, the maker of OxyContin, seeking to use a rare public appearance to extract admissions of personal responsibility for the deadly opioid epidemic as well as details about $10 billion that records show the family withdrew from the company.
The hearing, before the House Oversight Committee, offered a highly unusual opportunity for the public to hear directly from some members of the family, whose company is a defendant in thousands of federal and state lawsuits for misleading marketing of OxyContin, the painkiller seen as initiating a wave of opioid addiction that has led to the deaths of more than 450,000 Americans. Eight members of the family have been individually named in many state cases.
The singularity of the Sacklers’ appearance on Thursday was underscored by the likelihood that they may never testify in open court, because the ongoing bankruptcy proceedings and nationwide litigation may resolve in settlements rather than trials. Despite millions of dollars in legal expenses racked up by plaintiffs and Purdue alike — and the company’s subsequent filing for Chapter 11 bankruptcy protection in September 2019 — one obstacle to resolution persists: the refusal of the Sacklers to be held personally or criminally responsible and to turn over substantial portions of their fortune.
During the tense, nearly four-hour hearing, David Sackler, 40, and his cousin, Dr. Kathe Sackler, 72, who both served on the company’s board for years, largely sidestepped would-be booby traps and deflected blame to “management” and independent, nonfamily board members.
-snip-
It was the first time in years that members of the family that owns Purdue Pharma have taken questions publicly, and the exchanges were tense.
By Jan Hoffman
Dec. 17, 2020, 2:28 p.m. ET
Members of Congress on Thursday hurled withering comments and furious questions at two members of the billionaire Sackler family that owns Purdue Pharma, the maker of OxyContin, seeking to use a rare public appearance to extract admissions of personal responsibility for the deadly opioid epidemic as well as details about $10 billion that records show the family withdrew from the company.
The hearing, before the House Oversight Committee, offered a highly unusual opportunity for the public to hear directly from some members of the family, whose company is a defendant in thousands of federal and state lawsuits for misleading marketing of OxyContin, the painkiller seen as initiating a wave of opioid addiction that has led to the deaths of more than 450,000 Americans. Eight members of the family have been individually named in many state cases.
The singularity of the Sacklers’ appearance on Thursday was underscored by the likelihood that they may never testify in open court, because the ongoing bankruptcy proceedings and nationwide litigation may resolve in settlements rather than trials. Despite millions of dollars in legal expenses racked up by plaintiffs and Purdue alike — and the company’s subsequent filing for Chapter 11 bankruptcy protection in September 2019 — one obstacle to resolution persists: the refusal of the Sacklers to be held personally or criminally responsible and to turn over substantial portions of their fortune.
During the tense, nearly four-hour hearing, David Sackler, 40, and his cousin, Dr. Kathe Sackler, 72, who both served on the company’s board for years, largely sidestepped would-be booby traps and deflected blame to “management” and independent, nonfamily board members.
-snip-
Read more: https://www.nytimes.com/2020/12/17/health/opoids-sacklers-purdue-testimony.html
4 replies
= new reply since forum marked as read
= new reply since forum marked as read